Bladder infusion
Showing 1 - 25 of >10,000
Non-muscle-invasive Bladder Cancer Trial in Xi'an (Standard infusion chemo, BL - 5 ala PDT)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- Standard infusion chemotherapy
- BL - 5 ala PDT
-
Xi'an, Shaanxi, ChinaDalin He
Sep 19, 2022
Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG Trial in Canada, United States (TLD-1433 Bladder infusion and
Recruiting
- Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
- TLD-1433 Bladder infusion and Photodynamic Therapy
-
Bala-Cynwyd, Pennsylvania
- +10 more
May 6, 2022
Catheter Related Complication Trial in Roma (intrathecal infusion, Intravenous Infusion, Ropivacaine injection)
Completed
- Catheter Related Complication
- intrathecal infusion
- +2 more
-
Roma, Rome, ItalyAndrea
Nov 7, 2021
Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules
Recruiting
- Neoplasms
- +13 more
- HTL0039732 Capsules
- HTL0039732 Capsules and atezolizumab infusion
-
Cambridge, United Kingdom
- +4 more
Jul 5, 2023
Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,
Recruiting
- Sarcoma, Synovial
- +8 more
- CYCLOPHOSPHAMIDE and FLUDARABIN
- +3 more
-
Jerusalem, IsraelHadassah Medical Organization
Mar 15, 2022
Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)
Recruiting
- Bladder Cancer
- [68Ga]-NOTA-SGC8
-
Shanghai, Shanghai, ChinaRenji Hospital
Aug 14, 2023
Bladder Spasms Trial in Rochester (Magnesium, Placebo)
Not yet recruiting
- Bladder Spasms
- Magnesium
- Placebo
-
Rochester, MinnesotaMayo Clinic in Minnesota
Mar 23, 2023
Cancer, Bladder Trial in Mansoura (INTRATHECAL dexmedetomidine INJECTION)
Not yet recruiting
- Cancer, Bladder
- INTRATHECAL dexmedetomidine INJECTION
-
Mansoura, Dakahlia, EgyptMedicine
Mar 1, 2022
Influence of Timing PTCy in AlloSCT
Not yet recruiting
- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation
- (no location specified)
Jun 6, 2023
Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)
Not yet recruiting
- Non-muscular Invasive Bladder Cancer
- BCG for therapeutic use
-
Changsha, ChinaHunan Cancer Hospital
Oct 20, 2023
Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
-
Chengdu, Sichuan, ChinaWest China Hospital
Aug 10, 2023
Resectable Colon Cancer, Resectable NSCLC, Resectable Bladder Cancer Trial in Madrid, Seville (Colo-Ad1)
Completed
- Resectable Colon Cancer
- +3 more
- Colo-Ad1
-
Madrid, Spain
- +1 more
Mar 10, 2020
Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)
Not yet recruiting
- Urothelial Bladder Carcinoma
- Sacituzumab govitecan
- +2 more
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Nov 14, 2023
Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)
Not yet recruiting
- Advanced Urothelial Carcinoma
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 13, 2023
Bladder Cancer Trial in Spain (Atezolizumab Injection [Tecentriq], External Beam Radiation Therapy (EBRT))
Active, not recruiting
- Bladder Cancer
- Atezolizumab Injection [Tecentriq]
- External Beam Radiation Therapy (EBRT)
-
Manresa, Barcelona, Spain
- +9 more
Oct 25, 2022
Urothelial Carcinoma of the Bladder Trial in Washington, Baltimore, Philadelphia (drug, radiation, procedure)
Active, not recruiting
- Urothelial Carcinoma of the Bladder
- Methotrexate
- +7 more
-
Washington, District of Columbia
- +3 more
Dec 2, 2022
Metastatic Urothelial Carcinoma Trial (Pembrolizumab (200mg), Pembrolizumab (400mg), Monitoring)
Not yet recruiting
- Metastatic Urothelial Carcinoma
- Pembrolizumab (200mg)
- +2 more
- (no location specified)
Sep 18, 2023
Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating
Recruiting
- Urothelial Carcinoma
- Non-Invasive Bladder Urothelial Carcinoma
- Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
-
Tampa, FloridaMoffitt Cancer Center
Mar 2, 2023
Urinary Bladder Tumors Trial in Worldwide (Pembrolizumab, Conventional Radiotherapy (Bladder only), Conventional Radiotherapy
Recruiting
- Urinary Bladder Neoplasms
- Pembrolizumab
- +8 more
-
Washington, District of Columbia
- +120 more
Jan 19, 2023
fMRI Research Trial in Ghent (invasive urodynamic evaluation, functional magnetic resonance imaging during bladder filling)
Recruiting
- fMRI Research
- invasive urodynamic evaluation
- functional magnetic resonance imaging during bladder filling
-
Ghent, Flanders, BelgiumGhent University Hospital
Feb 21, 2022
Bladder Cancer Trial in Canada (Tranexamic Acid, Placebo)
Completed
- Bladder Cancer
- Tranexamic Acid
- Placebo
-
Edmonton, Alberta, Canada
- +9 more
Oct 3, 2022
18-45 Range of Age, Cesarean Section, Primigravid Trial in Erzurum (bupivacaine,fentanyl)
Completed
- 18-45 Range of Age
- +2 more
- bupivacaine,fentanyl
-
Erzurum, TurkeyAtaturk University
Nov 18, 2022